XML 36 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flow From Operating Activities:    
Net Income (Loss) $ 7,295,478 $ (1,756,050)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used) in Operating Activities:    
Depreciation and Amortization 521,486 539,070
Amortization of Lease Liability 117,986 117,986
Amortization of Debt Discount 0 17,534
Amortization of Software Costs 31,425 6,285
Equity Compensation Expense 307,686 87,033
Value of Equity Issued for Services 48,000 45,200
Reserve for Bad Debt 205,000 (190,000)
Inventory Reserve (100,000) 0
Decrease (Increase) in:    
Accounts Receivable (2,214,625) 1,161,434
Inventory (1,923,030) 276,438
Other Receivables (157,487) 0
Prepaid Expenses (189,095) (20,217)
Vendor Deposits (192,160) (109,689)
Other Assets (354,991) (130,692)
Increase (Decrease) in:    
Accounts Payable 1,436,766 (704,675)
Accrued Expenses 248,458 91,204
Accrued Interest (66,667) (50,000)
Accrued Officer Compensation 40,050 (39,833)
Customer Deposits 0 116,327
Lease Liability (109,747) (29,888)
Net Cash Provided by (Used in) Operating Activities 4,944,535 (572,533)
Cash Flow From Investing Activities:    
Capitalized Software Costs 0 (125,704)
Capitalized Patent Costs 0 (21,980)
Purchase of Property and Equipment (50,574) (140,647)
Net Cash Used in Investing Activities (50,574) (288,331)
Cash Flow From Financing Activities:    
Proceeds from Exercise of Warrants and Options 183,500 0
Proceeds from Loan Payable 410,700 0
Repayment of Principal Balance on Convertible Note (500,000) 0
Net Cash Provided By Financing Activities 94,200 0
Increase (Decrease) In Cash and Cash Equivalents 4,988,160 (860,864)
Cash and Cash Equivalents - Beginning 897,223 2,004,938
Cash and Cash Equivalents - Ending 5,885,383 1,144,075
Supplemental Cash Flow Information:    
Cash Paid for Interest 107,356 200,000
Cash Paid for Income Taxes 800 800
Non-Cash Investing and Financing Activities :    
Accrued Equity Compensation 27,189 59,845
Conversion of Note Payable into Common Stock 4,500,000 0
Equipment, Net Transferred to Inventory 36,256 0
Capitalization of patent costs reclassified from Other Assets $ 0 $ 36,227